Posts by Joshua Barney
February 8, 2023 UVA IDs Trigger for World’s Most Common Liver Disease
The new insights help explain the condition in younger people and may even help us slow or reverse aging.
February 1, 2023 UVA IDs Genes Responsible for Coronary Artery Disease
Coronary artery disease is the No. 1 cause of death worldwide. UVA's discovery opens the door to new and better treatments.
January 12, 2023 UVA Solves Mysteries about Leading Biomarker for Alzheimer’s
Scientists may be able to leverage the findings to develop new Alzheimer’s treatments and detect the disease much earlier, before symptoms develop.
December 21, 2022 COVID-19 Booster Increases Durability of Antibody Response
New research from the School of Medicine speaks to the benefits of a COVID-19 booster.
December 20, 2022 Potentially Deadly Infection Has Dangerous Ally Lurking in Our Guts
The discovery could help doctors identify patients at risk for severe C. difficile and open the door to new treatments.
December 19, 2022 Antidepressants, Infection Linked to Neurodevelopmental Disorders
Antidepressants may combine with inflammation during pregnancy to heighten the risk of lifelong neurodevelopmental changes in babies’ brains, such as those linked to autism, new research suggests.
December 5, 2022 iTHRIV Awards $200,000 to Pediatric, Prenatal and Cancer Research
iTHRIV has funded four multi-institution research projects that aim to accelerate health breakthroughs.
November 30, 2022 iTHRIV Backs Autism, HPV Efforts With $80,000 in Seed Grants
The two community-focused projects aim to help people with autism in crisis and reduce HPV vaccine hesitancy.
November 21, 2022 UVA Creates Potent Tool to Advance Genomics, Disease Research
In addition to advancing research and potentially accelerating new treatments, the new tool could help improve cancer diagnosis.
October 27, 2022 UVA Creates Shining ‘KSTAR’ to Guide Cancer Treatments
UVA researchers have developed an algorithm that will improve cancer care by quickly and easily identifying patients who will benefit from powerful cancer drugs called kinase inhibitors.